Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / ESCMID Global 2026 Faster Diagnostics at What Cost
Insights Point of care testing Screening and monitoring Infectious Disease Voices in the Community

ESCMID Global 2026: Faster Diagnostics at What Cost?

This year’s congress spotlights innovation and growing gaps in patient care

By Jessica Allerton 04/30/2026 Review 2 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Share

Objective:

To explore the advancements in diagnostic technologies and their implications for healthcare delivery, focusing on the balance between speed and quality.

Key Findings:
  • Faster diagnostics are essential but must be integrated into clinical workflows to improve patient outcomes, as evidenced by recent studies.
  • Neonatal sepsis and AMR remain significant challenges despite technological advancements, requiring ongoing research and innovation.
  • New diagnostic technologies are emerging, including AI and non-phenotypic methods, but integration into routine practice is challenging due to existing workflows.
  • Regulatory alignment is crucial for the safe adoption of new diagnostic tools, ensuring they meet quality standards.
Interpretation:

The rapid advancement of diagnostic technologies presents opportunities and challenges, necessitating careful consideration of quality, integration, and regulatory frameworks to ensure effective patient care.

Limitations:
  • Laboratories face pressure to deliver faster results without adequate resources, impacting the quality of diagnostics.
  • Integration of new technologies into existing workflows remains a significant hurdle, often requiring additional training and support.
Conclusion:

While innovations in diagnostics are promising, their effectiveness hinges on maintaining quality and ensuring they enhance clinical decision-making through proper integration.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Insights
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Turning Tides
Insights
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Insights
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Navigating Digital Scholarship and Professional Growth
Insights
Navigating Digital Scholarship and Professional Growth

January 16, 2024

5 min read

How can new-in-practice pathologists leverage the power of social media to enhance traditional academic work?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.